Syntron is a biopharmaceutical company with fully independent intellectual properties dedicated to the discovery and development of innovative drugs, as well as clinical research and commercialization worldwide.

The aim of our company is to provide patients with better treatment and lower costs.

The vision of our company is to synchronize China's new drug research and development with the world, provide breakthrough and innovative treatments against cancer, autoimmune diseases, and lead drug research and development across the world.

Our company's research and development centers are located at Beijing and Nanjing. The industrial base is located at Yancheng Binhai Pharmaceutical Industrial Park, Jiangsu Province. The company mainly focused on developing small-molecule immune check point inhibitors, antiviral inhibitors and diabetes complications treatment. With the enrichment of product pipelines and the exploration of combination therapy, our innovation areas are expected to expand to more types of drug development.

Medicine for Wellbeing, Fight for the Future.

synchronize China's new drug research and development with the world.

Being together, we are determined to develop innovative drugs that are more effective for patients around the world.